Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB

Joining a list that recently includes Pfizer, UCB and WuXi AppTec, Takeda Pharmaceuticals is the latest drugmaker to pull out of prominent industry lobbying group the Biotechnology Innovation Organization (BIO).